M. Oliveira

发表

Controlled Inflammatory Responses in the Lungs Are Associated with Protection Elicited by a Pneumococcal Surface Protein A-Based Vaccine against a Lethal Respiratory Challenge with Streptococcus pneumoniae in Mice

E. Miyaji, P. Ho, I. Raw, 2012, Clinical and Vaccine Immunology.

Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice.

E. Miyaji, P. Ho, L. Leite, 2004, Biochemical and biophysical research communications.

Molecular Cloning and Expression of a Functional Snake Venom Vascular Endothelium Growth Factor (VEGF) from the Bothrops insularis Pit Viper

P. Ho, S. P. Farsky, I. J. de Azevedo, 2001, The Journal of Biological Chemistry.

Aerobic exercise attenuates pulmonary inflammation induced by Streptococcus pneumoniae.

E. Miyaji, M. Martins, F. Almeida, 2014, Journal of applied physiology.

Angiostatin-like molecules are generated by snake venom metalloproteinases.

P. Ho, S. Serrano, R. Mentele, 2002, Biochemical and biophysical research communications.

Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges.

J. Villena, S. Alvarez, S. Salva, 2011, International immunopharmacology.

Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A

E. Miyaji, V. Monedero, G. Pérez-Martínez, 2006, Microbes and Infection.

Systems analysis of subjects acutely infected with the Chikungunya virus

H. Nakaya, P. Zanotto, A. Suhrbier, 2019, PLoS pathogens.

Efficacy of a Protein Vaccine and a Conjugate Vaccine Against Co-Colonization with Vaccine-Type and Non-Vaccine Type Pneumococci in Mice

E. Miyaji, M. Oliveira, Giuliana S Oliveira, 2020, Pathogens.

Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection

E. Miyaji, N. Kunda, I. Saleem, 2018, PloS one.

Optimized Immune Response Elicited by a DNA Vaccine Expressing Pneumococcal Surface Protein A Is Characterized by a Balanced Immunoglobulin G1 (IgG1)/IgG2a Ratio and Proinflammatory Cytokine Production

E. Miyaji, L. Leite, M. Darrieux, 2008, Clinical and Vaccine Immunology.

Pertussis Toxin Improves Immune Responses to a Combined Pneumococcal Antigen and Leads to Enhanced Protection against Streptococcus pneumoniae

C. Locht, N. Mielcarek, E. Miyaji, 2014, Clinical and Vaccine Immunology.

Evaluation of a Vaccine Formulation against Streptococcus pneumoniae Based on Choline-Binding Proteins

E. Miyaji, D. Briles, P. Ho, 2014, Clinical and Vaccine Immunology.

Impaired expression of CXCL5 and matrix metalloproteinases in the lungs of mice with high susceptibility to Streptococcus pneumoniae infection

E. Miyaji, O. Ribeiro, Fernanda Calheta Vieira Portaro, 2017, Immunity, inflammation and disease.

Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A

C. Locht, N. Mielcarek, E. Miyaji, 2020, PloS one.

Pneumococcal Vaccines: Past Findings, Present Work, and Future Strategies

E. Miyaji, M. Oliveira, Giuliana S Oliveira, 2021, Vaccines.

Mapping of Epitopes Recognized by Antibodies Induced by Immunization of Mice with PspA and PspC

E. Miyaji, D. Briles, P. Ho, 2014, Clinical and Vaccine Immunology.

Pneumococcal Surface Protein A does not affect the immune responses to a combined diphtheria tetanus and pertussis vaccine in mice.

E. Miyaji, P. Ho, I. Raw, 2013, Vaccine.

Serotype-independent pneumococcal vaccines

E. Miyaji, P. Ho, E. Carvalho, 2012, Cellular and Molecular Life Sciences.

Cross-Reactivity of Antipneumococcal Surface Protein C (PspC) Antibodies with Different Strains and Evaluation of Inhibition of Human Complement Factor H and Secretory IgA Binding via PspC

E. Miyaji, P. Ho, M. Martinez, 2012, Clinical and Vaccine Immunology.

Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice.

E. Miyaji, P. Ho, D. Ferreira, 2011, FEMS immunology and medical microbiology.

Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice

E. Miyaji, P. Ho, C. S. Takata, 2010, PloS one.

Intranasal vaccines for protection against resipratory and systemic bacterial infections

P. Ho, A. P. M. Arêas, M. Oliveira, 2007, Expert review of vaccines.

Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).

E. Miyaji, D. Briles, P. Ho, 2010, Microbial pathogenesis.

Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge.

E. Miyaji, P. Ho, L. Leite, 2008, Microbes and infection.

DNA vaccines expressing pneumococcal surface protein A (PspA) elicit protection levels comparable to recombinant protein.

E. Miyaji, P. Ho, L. Leite, 2006, Journal of medical microbiology.

Economical Value of Vaccines for the Developing Countries—The Case of Instituto Butantan, a Public Institution in Brazil

E. Miyaji, P. Ho, I. Raw, 2011, PLoS neglected tropical diseases.

Characterization of the antibody response elicited by immunization with pneumococcal surface protein A (PspA) as recombinant protein or DNA vaccine and analysis of protection against an intranasal lethal challenge with Streptococcus pneumoniae.

E. Miyaji, P. Ho, C. Chávez-Olórtegui, 2012, Microbial pathogenesis.